Annual Equity. You will be eligible to be granted annual equity incentive restricted stock units (“RSU”) awards with respect to shares of the Company’s non-voting common stock. For fiscal years beginning in 2022 and continuing through (and including 2025) the grant date value of such annual RSU awards is targeted to be at least Fifteen Million Dollars ($15,000,000), provided that such grants are not guaranteed and remain subject to approval by the Board (or an authorized committee thereof) each year and your continued employment at the time of grant, subject to the acceleration provisions of Section 5(c) herein. For avoidance of doubt, each annual equity award shall be made approximately once every 12 months beginning in 2022 and continuing through (and including) 2025. The number of shares underlying such annual RSU awards will be determined by the then-current per share valuation, either by reference to the most recent Company valuation, or, if the shares of the Company are publicly traded, the 30-trading day average closing price or such other share valuation methodology used by the Board (or an authorized committee thereof) at such time for other Company executive-level annual equity grants (each such annual RSU award, an “Annual Incentive Award”). Each Annual Incentive Award shall be granted on or around the time the Company grants annual equity incentives to its executive-level employees each fiscal year and will vest in equal quarterly installments until it is fully vested on the first anniversary of the grant date, subject to your continued employment with the Company through such vesting date, and to the terms and conditions set forth in the Company’s 2018 Equity Incentive Plan (or any other then-applicable Company equity incentive plan or award terms under which such Annual Incentive Award is granted) and the potential vesting acceleration described in Section 5 below. Notwithstanding the foregoing, the first Annual Incentive Award granted to you in fiscal 2022 shall be granted on or before the one (1) year anniversary of your Employment Start Date and will vest in equal quarterly installments over the period measured from the one-year anniversary of your Employment Start Date through the one (1) year anniversary of the grant date. In all circumstances, shares issued to you upon vesting of an Annual Incentive Award shall be issued no later than (a) December 31 of the calendar year in which the applicable vest date occurs (that is, the last day of your taxable y...
Annual Equity. You will be eligible to be granted annual equity incentive restricted stock units (“RSU”) awards with respect to shares of the Company’s non-voting common stock (each, an “Annual Incentive Award”). For fiscal years beginning in 2023 and continuing through (and including) 2025 the grant date value of such Annual Incentive Awards is targeted to be at least Fifteen Million Dollars ($15,000,000), provided that such grants are not guaranteed and remain subject to approval by the Board (or an authorized committee thereof) each year and your continued employment at the time of grant, subject to the acceleration provisions of Section 5(c) herein. Notwithstanding anything herein to the contrary, the target grant date value for the 2023 Annual Incentive Award will be reduced by the amount of any cash bonus opportunity (other than, for the avoidance of doubt, the Retention Bonus) that may be approved by the Board (or an authorized committee thereof) between October 1, 2022, and the grant date of the 2023 Annual Incentive Award. For avoidance of doubt, each Annual Incentive Award shall be made approximately once every 12 months beginning in 2023 and continuing through (and including) 2025. The number of shares underlying such Annual Incentive Awards will be determined by the then-current per share valuation, either by reference to the most recent Company valuation, or, if the shares of the Company are publicly traded, the 30-trading day average closing price or such other share valuation methodology used by the Board (or an authorized committee thereof) at such time for other Company executive-level annual equity grants. Each Annual Incentive Award shall be granted on or around the time the Company grants annual equity incentives to its executive-level employees each fiscal year and will vest in substantially equal quarterly installments until it is fully vested on the first anniversary of the grant date, subject to your continued employment with the Company through such vesting date and to the terms and conditions set forth in the Company’s 2018 Equity Incentive Plan (or any other then-applicable Company equity incentive plan or award terms under which such Annual Incentive Award is granted) and the potential vesting acceleration described in Section 5 below. Each Annual Incentive award may additionally be subject to the requirement that a liquidity event occurs during your continued employment. Upon vesting, the Company will issue you the shares underlying each Annu...
Annual Equity. 7.6.1 You will be eligible for annual equity awards as determined by the Compensation Committee of the Board of Directors of lululemon athletica inc. in its sole discretion as notified to You from time to time. Your eligibility will at all times be subject to and conditional upon the rules of any annual equity awards. The potential equity awards currently consist of stock options, restricted share units and performance share units. The Company reserves the right to vary or terminate (with or without any replacement awards) any annual equity awards in place from time to time.
Annual Equity. Award: Beginning Fiscal 2017, target equity value of at least $2,500,000 to be granted annually at the same time as annual awards to other executives, normally in May but may be earlier or later, and under terms of the equity program as approved each year by the Compensation and Organizational Development Committee of the Xxxxx Xxxxxx Corporation Board of Directors (“Compensation Committee”), including grant structure, type of awards, conversion of value to actual number of shares, and other applicable factors as determined by the Committee in its discretion.
Annual Equity. Beginning in February 2015 and continuing thereafter on an annual basis during the Term, Executive shall receive an annual equity grant based on terms and conditions that are comparable to those applicable to grants made to other senior executives of the Company, including achievement of personal or Company objectives established by the Board, and on such other terms applicable to other executives as are established by the Board in its reasonable discretion. For each year during the Term, the value of Executive’s annual equity grant is expected to be $800,000.00 (as measured on the date of grant and based on the Board’s assessment of the Company’s performance against Executive’s and the Company’s performance objectives). In accordance with the policies and practices of the Company, some or all of any annual equity grant may be in the form of restricted stock, stock options, stock units or other equity that is an economic equivalent to an option or a restricted stock award. Such equivalency will be determined by the Board in its reasonable discretion.
Annual Equity. Employee shall be eligible to participate in the annual equity incentive program of Parent and receive grants of equity or equity-based awards which may be options (each, an “Equity Award”), with vesting over four years, subject to the terms and conditions of Parent’s Omnibus Equity Incentive Plan (the “EIP”) and Parent’s standard form of award agreement. Employee’s Equity Award for the 2022 calendar year shall be a number of options to purchase Parent’s common stock with an equivalent value of $378,000 on the date of grant. During the Term for 2023 and annually thereafter, Employee’s Equity Award shall have a target value of (150% of Base Compensation) $630,000 as of the date of grant and it is intended that such award be made in options.
Annual Equity. Executive shall continue to receive an annual equity grant based on terms and conditions that are comparable to those applicable to grants made to other senior executives of the Company, including achievement of personal or Company objectives established by the Board, and on such other terms applicable to other executives as are established by the Board in its reasonable discretion. For each year during the Term, the value of Executive’s annual equity grant is expected to be $800,000.00 (as measured on the date of grant and based on the Board’s assessment of the Company’s performance against Executive’s and the Company’s performance objectives). In accordance with the policies and practices of the Company, some or all of any annual equity grant may be in the form of restricted stock, stock options, stock units or other equity that is an economic equivalent to an option or a restricted stock award. Such equivalency will be determined by the Board in its reasonable discretion.
Annual Equity. Executive shall continue to receive an annual equity grant based on terms and conditions that are comparable to those applicable to grants made to other senior executives of the Company, including achievement of personal or Company objectives established by the Board, and on such other terms applicable to other executives as are established by the Board in its reasonable discretion. In accordance with the policies and practices of the Company, some or all of any annual equity grant may be in the form of restricted stock, stock options, stock units or other equity that is an economic equivalent to an option or a restricted stock award; provided, however, that the annual equity grant in 2022 is expected to be 50% in the form of performance stock units, 30% in the form of restricted stock units, and 20% in the form of stock options. It is also expected that Executive’s equity grants received in 2021 will have an aggregate grant date fair value of approximately $2.0 million.
Annual Equity. Executive will be eligible for consideration for future annual stock-based awards in accordance with UnitedHealth Group’s governance policy and guideline amounts authorized by UnitedHealth Group’s Compensation and Human Resources Committee. For calendar year 2022, management will recommend that Executive be awarded an annual equity grant with a target value of $4,500,000. The actual grant value of any such future equity grants and the related terms are at the sole discretion of UnitedHealth Group and will be subject to the terms of the UnitedHealth Group 2020 Stock Incentive Plan (or a successor plan), including certain restrictive covenants.
Annual Equity. Rights Prior to January 15, 2006 Executive shall receive a grant of stock appreciation rights or by mutual agreement of the Company and the Executive, stock options for 100,000 shares of Company common stock at an exercise price per share equal to Fair Market Value (as defined in the Plan) on the date of grant (the “Annual Award”). Subject to Executive’s continued employment with the Company, such Annual Award will vest in equal installments on each of the first three anniversaries of the date of grant, and will become fully vested upon the occurrence of a Change in Control of the Company as defined in the Plan and the award certificate. Other terms and conditions of the Annual Award shall be as set forth herein, in the Plan and the award certificate. If the Company should, prior to any Annual Award grant, be involved in any merger, reorganization, stock split or spinoff or other similar event, the number of shares subject to the Annual Award yet to be granted, as provided above, shall be adjusted on a pro rata basis.
